Clinical Trial: Retinal OCTA for Microvascular Dysfunction Evaluation and Outcome Prediction in MINOCA Patients

U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07055152) titled 'Retinal OCTA for Microvascular Dysfunction Evaluation and Outcome Prediction in MINOCA Patients' on June 19.

Brief Summary: The aim of this study is to evaluate microvascular dysfunction through OCTA in MINOCA patients. In order to better understand the condition, OCTA will also be performed in two matched patient groups: healthy controls and ACS patients. The study will compare the retinal microvascular parameters across these groups to determine differences in microvascular function in MINOCA patients. Additionally, in the MINOCA subgroup, the study will further evaluate the differences in microvascular dysfunction within specific ...